YieldMax ETFs is set to execute reverse stock splits for 15 of its option income strategy funds, effective prior to market open on Dec. 1, Dec. 2, and Dec. 8, 2025. The reverse stock splits will ...
Tilray Brands shares are trading lower in Wednesday's after-hours session after the company announced a reverse stock split.
The Reverse Stock Split is expected to be effective at 4:01 pm Eastern Time on December 1, 2025 (the “Effective Date”) and shares of the Company’s common stock will begin trading on a split-adjusted ...
In a bid to get it above the NASDAQ-required minimum, Polestar ($PSNY) is rumored to be considering a 1:30 reverse stock ...
ULTY's strategy of holding volatile stocks and writing call options has resulted in high yields. Find out why the fund is a ...
InvestorsHub on MSN
Moleculin Biotech Shares Slide After Announcing 1-for-25 Reverse Split
Moleculin Biotech Inc. (NASDAQ:MBRX) saw its shares tumble 20.6% in premarket trading on Wednesday after unveiling plans for ...
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-8 reverse split of its issued and outstanding and ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State ...
The Reverse Stock Split is expected to be effective at 4:30 p.m. Eastern Time on December 1, 2025 (the " Effective Time "). The Company's common stock is expected to begin trading on a split-adjusted ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...
The Singapore-based property developer revealed that its board of directors approved a one-for-eight reverse split of its Class A ordinary shares on November 24, 2025. The company’s shares will begin ...
Investing.com -- Moleculin Biotech Inc (NASDAQ:MBRX) stock fell 20.6% in premarket trading Wednesday after the company announced a 1-for-25 reverse stock split set to take effect on December 1, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results